Coherus BioSciences Inc
CHRS
$0.99-7.48%
End of day · as of Oct 18, 2026, 2:01 AM ET
Mkt cap
$223.66M
EV/Sales
3.20
P/E ratio
N/A
FY2025 Revenue
$42.17M
EPS (TTM)
$-1.05
Gross Margin (FY2025)
67.24%
Profit Margin (FY2025)
398.43%
Beta
0.96
Div yield
N/A
Sector
Healthcare
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Latest reported CHRS revenue for 2025-12-31 was $42.2M. Net income was $168.0M. Revenue was down 84.2% from 2024-12-31 to 2025-12-31. CHRS currently screens at market cap $223.7M.
Use this CHRS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CHRS income, balance, and cash tables.
Coherus BioSciences Inc (CHRS) is a biotechnology company in the Healthcare sector.
Latest cached Coherus BioSciences Inc (CHRS) revenue for Dec 31, 2025 was $42.2M. Net income was $168.0M. Statements: https://lician.com/financials/chrs
Coherus BioSciences Inc (CHRS) market capitalization is $223.7M on the latest cached snapshot.
Coherus BioSciences Inc (CHRS) cached previous close $1.07; day range $0.99 – $1.07; volume 936,624. Session quote: https://lician.com/quote/chrs
Coherus BioSciences Inc (CHRS) latest cached earnings event is "CHRS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CHRS filing is 8-K · Aug 28, 2026. Filings: https://lician.com/sec/chrs